A retrospective comparison of pharmacist-managed versus infectious-diseases managed travel health services at an academic medical center

Clicks: 16
ID: 328195
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #201 of 249 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 249 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Purpose International travel is increasing, creating a need for accessible, high-quality travel health services. Pharmacists are positioned to expand access; transitioning services from infectious disease (ID) clinics to pharmacist-managed models may improve access and streamline the delivery system. This study compared vaccine acceptance and travel health recommendations between ID clinician and pharmacist-managed clinics at an Academic Medical Center. Methods This was a retrospective cohort study of electronic health record data for adults ≥18 years. ID clinician-managed visits (February–August 2023) were compared to pharmacist-managed visits (February–August 2024). The primary outcome was travel-related vaccine acceptance. Secondary outcomes included routine CDC vaccine acceptance, over-the-counter recommendations, and prescribed pharmacotherapy. Results A total of 337 patients were included (167 pharmacist-managed; 170 ID-managed). Travel vaccine recommendations were largely comparable, with no significant differences in acceptance for frequent recommendations like typhoid (84% vs 85%; P=0.88) and hepatitis A (47% vs 46%; P=0.83). However, routine CDC vaccine recommendations differed by clinic type; pharmacists more frequently recommended COVID-19, influenza, and herpes zoster vaccines (P<0.001). Pharmacists more frequently prescribed traveler’s diarrhea treatment (59% vs 24%; P<0.001). Rates of anti-malarial prophylaxis prescriptions were high in both groups and did not differ significantly (62% vs 58%; P=0.50). Conclusions Pharmacist-managed travel clinic achieved travel-related vaccine acceptance rates comparable to ID-managed clinics. Pharmacists more frequently recommended routine ACIP vaccines and prescribed traveler's diarrhea treatment. These findings suggest that pharmacist-managed travel health services under a collaborative practice agreement can deliver guideline-concordant care while possibly expanding institutional capacity.
Reference Key
openalex_W7212120440 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Julie MacDougall, Charles H. Miller, Alyssa Cappelluti, Kavita Vadlamani, Lauren Senesac, Peter Callas, Amanda G Kennedy
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag266
URL
https://doi.org/10.1093/ajhp/zxag266
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.